Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veterans

BACKGROUND: Given the paucity of information on dose intensity, the objective of this study is to describe the use of adjuvant chemotherapy for stage III colon cancer, focusing on relative dose intensity (RDI), overall survival (OS) and disease-free survival (DFS). METHODS: Retrospective cohort of 3...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Aspinall, Sherrie L, Good, Chester B, Zhao, Xinhua, Cunningham, Francesca E, Heron, Bernadette B, Geraci, Mark, Passero, Vida, Stone, Roslyn A, Smith, Kenneth J, Rogers, Renee, Shields, Jenna, Sartore, Megan, Boyle, D Patrick, Giberti, Sherry, Szymanski, John, Smith, Doug, Ha, Allen, Sessions, Jolynn, Depcinski, Shawn, Fishco, Shane, Molina, Irvin, Lepir, Tanja, Jean, Carmela, Cruz-Diaz, Lymaris, Motta, Jessica, Calderon-Vargas, Rebeca, Maland, Janelle, Keefe, Sean, Tague, Marshall, Leone, Alice, Glovack, Brian, Kaplan, Blair, Cosgriff, Sean, Kaster, Lindsay, Tonnu-Mihara, Ivy, Nguyen, Kimmai, Carmichael, Jenna, Clifford, Linda, Lu, Kan, Chatta, Gurkamal
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4352567/
https://ncbi.nlm.nih.gov/pubmed/25884851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1038-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados